Lee's Pharm In-licenses Neo-Natal Pulmonary Drug for China

Lee's Pharmaceutical of Hong Kong partnered with Ikaria, a US company, to register and market Ikaria's Inomax ® Total Care package in greater China. Inomax, an inhaled nitric oxide, is a vasodilator that treats hypoxic respiratory failure in infants greater than 34 weeks of gestational age. It is the only therapy approved by the US FDA for the condition. Terms of the partnership were not disclosed. More details.... Stock Symbol: (HK; 0950) Share this with colleagues: // //